Thus, our results demonstrate that lncRNA H19 is an important mediator of BMP9 signaling, suggesting that a balanced lncRNA H19 expression may play an essential role in BMP9-induced osteogenic differentiation of MSCs, and that disruptions of H19 expression may impair normal osteogenesis, leading to pathogenic processes such as bone tumor development. Here, H19 is linked to bone neoplasm.